COVACERT
DEAD
Serial Number
77057578
Owner
AMGEN INC.Attorney
Mark I. Feldman, Christina L. MartiniFiling Date
Dec 5, 2006
COVACERT Trademark
Serial Number: 77057578
COVACERT is a trademark filed by
AMGEN INC.
on December 5, 2006. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
December 5, 2006
Registration Date
Not Registered
Published for Opposition
August 28, 2007
Goods & Services
Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith
Filing History
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 21, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 21, 2010 ABN6
SOU EXTENSION 4 GRANTED
Oct 29, 2009 EX4G
SOU EXTENSION 4 FILED
Oct 27, 2009 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 27, 2009 EEXT
SOU EXTENSION 3 GRANTED
Apr 13, 2009 EX3G
SOU EXTENSION 3 FILED
Apr 8, 2009 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 8, 2009 EEXT
SOU EXTENSION 2 GRANTED
Sep 29, 2008 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 29, 2008 AITU
SOU EXTENSION 2 FILED
Sep 26, 2008 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 26, 2008 EEXT
SOU EXTENSION 1 GRANTED
Apr 23, 2008 EX1G
SOU EXTENSION 1 FILED
Apr 16, 2008 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 16, 2008 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 20, 2007 NOAM
PUBLISHED FOR OPPOSITION
Aug 28, 2007 PUBO
NOTICE OF PUBLICATION
Aug 8, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 23, 2007 PREV
ASSIGNED TO LIE
Jul 23, 2007 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2007 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2007 TROA
ASSIGNED TO EXAMINER
Jun 12, 2007 DOCK
NON-FINAL ACTION E-MAILED
Mar 30, 2007 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2007 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2007 DOCK
NEW APPLICATION ENTERED
Dec 8, 2006 NWAP
